Most multiple myeloma studies involve people of European descent, but the disease is more likely to affect African-Americans.
Direct to consumer testing can potentially be quite dangerous without appropriate regulations and support to fully understand the implications of the information a consumer receives.
The FDA has warned that it will be coming down hard on anyone carrying out do-it-yourself gene therapy, in a recent statement.
Moderna Therapeutics has began taking the steps to produce a cancer vaccine based on the growing volume of research on messenger RNA (mRNA).
Researchers have used CRISPR to genetically engineer a transgenic mosquitoe species, which could lead to the eventual eradication of a species.
Fabric Genomics Announces expanded oncology solution, extending somatic cancer analysis to clinical labs.
Scientists have managed to genetically modify a common beetle to develop a third functional eye, right in the middle of its forehead.
We caught up with patient advocate Karen Keeley ahead of Festival of Genomics London 2018.
Northern Biologics has appointed former Shire R&D chief Paul Vickers as CEO, putting him in charge of the Celgene-partnered biotech.
Myriad Genetics plans to partner with the US Department of Veterans Affairs to assess the company’s GeneSight genetic test in veterans with depression.
It has been reported that some people have two different sets of DNA, and if they do, they are known as human chimeras. This can happen a number of ways.
Dolomite Bio has launched the Nadia single cell platform, offering the fast-growing single cell research sector a solution for a range of applications.